TP53 and head and neck neoplasm: Loss of TP53 function is one of the most common genetic alterations in squamous cell carcinoma (SCC) of the head and neck [15], [36], [37] and head and neck tumors with disruptive TP53 mutations have been found to be more likely metastatic and to have worse survival [15].